Tasmanian medical research charity funds projects that have a global impact and improve community health and well-being.
- Tasmanian medical research charity funds projects that support community health and well-being, with clinicians and researchers working across the health system and university.
- Tasmanian medical research on childhood cataracts and gene variants can be easily studied and applied globally due to the small population and genetic diversity of the island state.
- The Royal Hobart Hospital Research Foundation funds medical research in various fields to support the Tasmanian community, in areas such as cardiothoracic, neurological conditions, and premature babies.
- Research supported by RHHRF has led to the development of innovative treatments for JackJumper ant bites, resulting in the establishment of a desensitisation clinic at the hospital and a significant reduction in deaths from anaphylactic shocks caused by these bites.
- Tasmanian medical research has had a global impact, with projects like the Hobart Method being implemented in neonatal clinics worldwide, and blood pressure testing research involving patients from Tasmania, China, Italy, and other countries.
Australian Health Journal spoke to Stephanie Furler the Chief Executive Officer of The Royal Hobart Hospital Research Foundation about the impact of this research locally and in global health.
You Might also like
-
Roadmapping next phase of Australia’s vaccine success
Trust, collaboration and a stronger vaccine ecosystem were the focus of the second Australian Vaccine Value Chain Conference, held in Sydney, September 2026 and hosted by life science consultancy Biointelect. More than 200 leaders from government, industry, academia, research, investment and the immunisation community attended, joined by international representatives including the International Vaccine Institute and the Coalition for Epidemic Preparedness Innovations.
-
Impact of genetic pathologist role across medicine
Dr Marina Berbic is a genetic pathologist and the Deputy Director of Genetics at Douglass Hanly Moir Pathology – a laboratory based in Sydney and part of Sonic Healthcare. The genetics department at Douglass Hanly Moir offers a wider array of genetic tests across many domains, and the medical leadership model ensures the highest possible standard of care and commitment to patient safety.
-
Addressing Pharmacy challenges at home and abroad
Paul Sinclair’s progression through the ranks of the International Pharmaceutical Federation (FIP) demonstrates the impact and influence he’s had in representing the pharmacy profession on a global scale. In this Australian Health Journal interview, Paul talks about the 4 themes in the upcoming FIP Congress in Brisbane this month. He also talks about the challenges facing pharmacy with remuneration, professional service delivery and the workforce coming out of the COVID era.